Literature DB >> 17889953

Pael receptor is involved in dopamine metabolism in the nigrostriatal system.

Yuzuru Imai1, Haruhisa Inoue, Ayane Kataoka, Wang Hua-Qin, Masao Masuda, Toshio Ikeda, Kayoko Tsukita, Mariko Soda, Tohru Kodama, Tatsu Fuwa, Yoshiko Honda, Satoshi Kaneko, Sadayuki Matsumoto, Kazumasa Wakamatsu, Shosuke Ito, Masami Miura, Toshihiko Aosaki, Shigeyoshi Itohara, Ryosuke Takahashi.   

Abstract

Pael receptor (Pael-R) has been identified as one of the substrates of Parkin, a ubiquitin ligase responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When Parkin is inactivated, unfolded Pael-R accumulates in the endoplasmic reticulum and results in neuronal death by unfolded protein stress, suggesting that Pael-R has an important role in the pathogenesis of AR-JP. Here we report the analyses on Pael-R-deficient (KO) and Pael-R-transgenic (Tg) mice. The striatal dopamine (DA) level of Pael-R KO mice was only 60% of that in normal mice, while in Pael-R Tg mice, striatal 3,4-dihydroxyphenylacetic acid (DOPAC) as well as vesicular DA content increased. Moreover, the nigrostriatal dopaminergic neurons of Pael-R Tg mice are more vulnerable to Parkinson's disease-related neurotoxins while those of Pael-R KO mice are less. These results strongly suggest that the Pael-R signal regulates the amount of DA in the dopaminergic neurons and that excessive Pael-R expression renders dopaminergic neurons susceptible to chronic DA toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889953     DOI: 10.1016/j.neures.2007.08.005

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  13 in total

1.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

2.  GPR37L1 modulates seizure susceptibility: Evidence from mouse studies and analyses of a human GPR37L1 variant.

Authors:  Michelle M Giddens; Jennifer C Wong; Jason P Schroeder; Emily G Farrow; Brilee M Smith; Sharon Owino; Sarah E Soden; Rebecca C Meyer; Carol Saunders; J B LePichon; David Weinshenker; Andrew Escayg; Randy A Hall
Journal:  Neurobiol Dis       Date:  2017-07-06       Impact factor: 5.996

3.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.

Authors:  Brilee M Smith; Michelle M Giddens; Jessica Neil; Sharon Owino; TrangKimberly T Nguyen; Duc Duong; Fengqiao Li; Randy A Hall
Journal:  Neuroscience       Date:  2017-06-20       Impact factor: 3.590

Review 4.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.

Authors:  Rebecca C Meyer; Michelle M Giddens; Stacy A Schaefer; Randy A Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

6.  G protein-coupled receptor expression in the adult and fetal adrenal glands.

Authors:  Yewei Xing; Yasuhiro Nakamura; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2008-11-05       Impact factor: 4.102

7.  Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.

Authors:  Myles R McCrary; Michael Q Jiang; Michelle M Giddens; James Y Zhang; Sharon Owino; Zheng Z Wei; Weiwei Zhong; Xiaohuan Gu; Huang Xin; Randy A Hall; Ling Wei; Shan P Yu
Journal:  FASEB J       Date:  2019-07-03       Impact factor: 5.834

8.  The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.

Authors:  Xavier Morató; Rafael Luján; Marc López-Cano; Jorge Gandía; Igor Stagljar; Masahiko Watanabe; Rodrigo A Cunha; Víctor Fernández-Dueñas; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

9.  GPR37 Signaling Modulates Migration of Olfactory Ensheathing Cells and Gonadotropin Releasing Hormone Cells in Mice.

Authors:  Hassan Saadi; Yufei Shan; Daniela Marazziti; Susan Wray
Journal:  Front Cell Neurosci       Date:  2019-05-09       Impact factor: 5.505

10.  Mutation in Parkinson disease-associated, G-protein-coupled receptor 37 (GPR37/PaelR) is related to autism spectrum disorder.

Authors:  Eriko Fujita-Jimbo; Zhi-Ling Yu; Hong Li; Takanori Yamagata; Masato Mori; Takashi Momoi; Mariko Y Momoi
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.